A part of Watch Media

MedWatchMonday29 May 2023

  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
MedWatchMonday29 May 2023
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Foto: Ambu / Pr

Ambu blames hospital staff shortage for European setback

The medtech company’s negative growth in Europe is being worked on, emphasizes the company’s CEO, Britt Meelby Jensen.

For subscribers

Coloplast and its CFO, Anders Lonning Skovgaard, still struggle to fire up growth on the Chinese market, but the company is now recommencing a list of sales activities. | Foto: Coloplast / Pr

Chinese problems halt growth – but optimism is spreading at Coloplast

For subscribers

Foto: Coloplast / Pr

Analyst: Restricted hospital access in China to dampen Coloplast's quarterly growth

Foto: Beta Bionics/pr

Beta Bionics granted FDA approval for bionic pancreas

For subscribers

The Russians that are already using Coloplast products can continue to do so while Ambu has "just about" discontinued sales in the country. | Foto: Maxim Zmeyev/reuters/ritzau Scanpix

Difficult company exits from Russia confirm Coloplast's choice to stay

For subscribers

Olympus reports double-digit growth in several endoscope areas

For subscribers

  • Chief Executive Officer of Coloplast Kristian Villumsen. | Foto: Stine Bidstrup

    Coloplast wants data on new ostomy product before deciding market viability

    Coloplast CEO Kristian Villumsen says data for ostomy leakage product Heylo is expected to be ready after the summer, with launch still scheduled for 2023.

    For subscribers

  • Foto: Coloplast / Pr

    Coloplast grows according to plan, adjusts expectations slightly

    However, a currency headwind draws down figures closer to home.

    For subscribers

  • It's possibly Coloplast's new catheter, Luja, that the company is measuring up against competing market products in clinical trials.

    Coloplast to compare new single-use catheter with competing product

    A new crossover study is meant to determine whether a new catheter from Coloplast is better than US Hollister’s catheter for women.

    For subscribers

  • Foto: Ambu/pr

    Analyst: Ambu disappoints on key figures despite positive top line

    Wednesday’s financial report from Ambu is disappointing in terms of overall results and the bottom line. However, the top line development is positive, is the evaluation from Sydbank analyst.

    For subscribers

  • Foto: Ambu/pr

    Ambu's revenues and earnings disappoint despite top-line growth

    Growth in the second quarter is a little weaker than the consensus estimate, while the Danish medtech company’s profit has seen a sharp year-over-year drop. 

    For subscribers

  • Foto: Ambu/pr

    Analyst sees Ambu endoscope sales as driving growth

    Sydbank analyst Søren Løntoft Hansen expects Ambu’s core business, anaesthesia and patient monitoring, to experience a more moderate growth in the coming report for Q2.

    For subscribers

  • Foto: Pr / Bavarian Nordic

    Ambu finds new COO at biotech firm

    Henrik Birk has previously served as chief operating officer at Bavarian Nordic.

    For subscribers

  • Foto: Coloplast / Pr

    Coloplast improves pulmonary health in recent study

    Coloplast’s new range of heat and moisture exchangers and adhesives, dubbed Provox Life, improves pulmonary health and quality of life for people living with laryngectomy.

    For subscribers

  • Ambu's new factory is not yet at full capacity, meaning electricity use per product is high | Foto: Ambu / Pr

    Mexico plant weighs down Ambu's climate account

    Though a newly established plant in Juárez is halting Ambu’s climate efforts, CEO Britt Meelby Jensen won’t resort to buying green certificates there, like it already does in China.

    For subscribers

  • Ambu did not make the development of a second-generation laryngoscope a top priority, and is therefore now falling behind a competitor on the market | Foto: Ambu/pr

    Ambu competitor takes the lead in US and UK

    While Ambu was busy focusing on its gastroscopy area, US-based Verathon launched a product for airway procedures. ”They’ve got a head start,” says Ambu’s CEO, Britt Meelby Jensen.

    For subscribers

  • The acquisition of Atos Medical was the biggest in Coloplast's history | Foto: Coloplast / Pr

    Coloplast's newest business area could become its biggest

    Atos Medical could accelerate growth and, in the long term, become the Danish medtech company’s most important business leg, says the unit’s chief.

    For subscribers

  • VivaSight can now again be employed by doctors and nurses after the product was removed from the market for almost a year | Foto: Ambu/pr

    Ambu relaunches formerly recalled product

    Since May of last year, the Danish medtech company has been working on correcting a safety flaw on a key product within its pulmonology suite.

    For subscribers

  • Foto: Coloplast / Pr

    Coloplast testing silicone dressing against standard care

    In a clinical trial, the Danish medtech company will demonstrate that the Biatain Silicone dressing is better than commonly used wound care products.

    For subscribers

  • Juan Jose Gonzalez, new CEO of PolyPeptide Group. | Foto: Ambu/pr

    Former Ambu CEO to spearhead Swiss biotech company

    Juan Jose Gonzalez, who was let go from Ambu in May 2022, finds himself another chief executive position.

    For subscribers

  • It is rather new for Coloplast to be conducting clinical trials of its equipment, says one analyst | Foto: Coloplast / Pr

    Analyst: Coloplast study attests to Luja as premium product

    The Danish medtech company showed up a competitor last week in a study of a new male catheter product. 

    For subscribers

  • Nicolai Buhl, executive vice president for innovation at Coloplast, is busy winning a clinical contest against a catheter competitor | Foto: Mik Eskestad

    Coloplast challenges its biggest catheter competitor in clinical contest

    The Danish medtech company seeks to take market shares from US-based Hollister by comparing respective catheters, hoping to charge a higher price.

    For subscribers

  • Foto: Ambu/pr

    Ambu wins European approval of two fifth-generation bronchoscopes

    With two recent approvals, the Danish medtech company says it now offers a full portfolio of single-use bronchoscopes.

    For subscribers

  • Foto: Synlab / Pr

    Novo Holdings could earn big on acquisition bid for Synlab

    With 17% ownership of the laboratory services provider, Novo Holdings would likely make a pretty penny if an acquisition offer is accepted. 

    For subscribers

  • Foto: Ambu/pr

    Nordnet sees reason in Ambu's speedy capital raise

    ”Ambu should now consider itself as financially free as bird and ready to soar,” assesses a Nordnet analyst.

    For subscribers

  • Foto: Ambu/pr

    Ambu share offering complete at 4.7% discount

    The Danish medtech company has raised DKK 1.1bn.

    For subscribers

Latest news

  • Ambu blames hospital staff shortage for European setback – 12:44
  • A weight loss startup touting mindfulness, Noom is now prescribing drugs – 10:14
  • Heartseed raises USD 14m for stem-cell therapy development – 07:22
  • Top news from MedWatch this week – 26 May
  • CHMP recommends two drugs in May – 26 May
  • Demant proposes partial Oticon Medical divestment to ease competition concerns – 26 May
  • GN considers Covid-19 situation far less critical than six months ago – 26 May
  • Almirall to collaborate with Spanish research center on skin cancer treatment – 26 May
  • Novo Nordisk wins EU recommendation for label extension of long-acting growth hormone – 26 May
  • Novo Nordisk's semaglutide shows potential against addiction – 26 May
See all

Jobs

  • Design Control Specialist - ensure safe, high-quality products

  • QA Project Manager - ensure high-quality health care products

  • IT Project Manager

  • QA Consultant to our Inhouse Team

  • Clinical Trial Manager

  • Senior Scientist, Analytical Development

  • Medical Advisor within Neurology

  • Senior Safety Surveillance Advisor

  • Senior Quality Specialist Business Support Team, Medical Devices, Ferrosan

  • Medical Writer

  • Senior/Principal Scientist Pharmacology & Biology, Synklino

  • Senior Process Engineer with Project Experience

  • Sterilisation Specialist for Global Quality, RA & Sustainability, Quality Competence Center

  • Chief Commercial Officer

  • Manager of Quality Assurance Operation Support Team, Medical Devices, Ferrosan Medical Devices

  • Senior Drug Product Specialist, Zealand Pharma

  • Senior Principle Project Portfolio Manager

  • Experienced Bioanalytical Scientist

  • Clinical Project Director

  • Experienced Scientist, Oncology Research

  • Regulatory Affairs Specialist

  • Academic staff member for Environmental Monitoring - Aseptic Production

  • Regulatory Affairs Specialist for innovation projects

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

  • About MedWatch

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Banner Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved